Citizens Jmp Issues Positive Forecast for Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price

Sabra Healthcare REIT (NASDAQ:SBRA) had its price target increased by Citizens Jmp from $22.00 to $23.00 in a report released on Wednesday,Benzinga reports. They currently have a market outperform rating on the real estate investment trust’s stock.

Other analysts also recently issued research reports about the company. Truist Financial lifted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a research report on Tuesday, January 20th. Wells Fargo & Company lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Citigroup increased their price target on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday. Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Thursday, January 22nd. Finally, Cantor Fitzgerald upped their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Tuesday. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $21.60.

Sabra Healthcare REIT Stock Down 2.7%

Shares of NASDAQ:SBRA opened at $20.03 on Wednesday. The firm has a fifty day moving average price of $19.10 and a two-hundred day moving average price of $18.81. The company has a market cap of $5.05 billion, a price-to-earnings ratio of 31.30, a PEG ratio of 1.45 and a beta of 0.67. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. Sabra Healthcare REIT has a one year low of $15.60 and a one year high of $20.70.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The business had revenue of $201.35 million during the quarter, compared to analysts’ expectations of $201.97 million. During the same quarter last year, the business posted $0.36 EPS. The company’s quarterly revenue was up 16.2% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Analysts anticipate that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 27th. Investors of record on Friday, February 13th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 13th. This represents a $1.20 annualized dividend and a dividend yield of 6.0%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 187.50%.

Hedge Funds Weigh In On Sabra Healthcare REIT

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Principal Financial Group Inc. grew its stake in shares of Sabra Healthcare REIT by 21.6% in the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after purchasing an additional 4,431,897 shares during the last quarter. Lasalle Investment Management Securities LLC bought a new stake in shares of Sabra Healthcare REIT in the 4th quarter worth approximately $66,938,000. Engineers Gate Manager LP grew its position in shares of Sabra Healthcare REIT by 3,190.3% in the 2nd quarter. Engineers Gate Manager LP now owns 3,179,303 shares of the real estate investment trust’s stock worth $58,626,000 after buying an additional 3,082,677 shares during the last quarter. Norges Bank purchased a new position in shares of Sabra Healthcare REIT during the fourth quarter valued at approximately $57,945,000. Finally, Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Sabra Healthcare REIT by 1,019.8% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock valued at $56,922,000 after acquiring an additional 2,736,993 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.